Medication info

Selcita Tablet 50 mg (Sitagliptin Hydrochloride Hydrate)

Prescription medicationTabletOralExpired
Ingredient · strength
Sitagliptin Hydrochloride Hydrate›56.7mg / 1 tablet
Manufacturer / importer
Celltrion Pharmaceutical Co., Ltd.
Appearance
Light orange, round, biconvex film-coated tablet
Packaging
28 tablets (14 tablets/PTP x 2) - 14 tablets/PTP [28 tablets (14 tablets/PTP x 2)], 30 tablets (10 tablets/PTP x 3) - 10 tablets/PTP [30 tablets (10 tablets/PTP x 3)]
Approval status
Expired

MFDS item code 202005877 · Approved 2020.08.18

This product's status changed to Expired on 2025.08.18. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Improvement of glycemic control in type 2 diabetes mellitus
Who takes it
Adults
Adult dose
Administer 100mg once daily as monotherapy or combination therapy; the maximum daily dose is 100mg. This medicine may be taken with or without food. When coadministered with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of sulfonylurea- or insulin-induced hypoglycemia (see Precautions for Use, 5. General Precautions). Patients with renal impairment Because dose adjustment according to renal function is required, assessment of renal function is recommended before starting this medicine and periodically during treatment. 1. No dose adjustment is required in patients with mild renal impairment (estimated glomerular filtration rate [eGFR] ≥ 60 mL/min/1.73 m2 and < 90 mL/min/1.73 m2). 2. No dose adjustment is required in patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 45 mL/min/1.73 m2 and < 60 mL/min/1.73 m2). 3. Administer 50 mg once daily to patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 30 mL/min/1.73 m2 and < 45 mL/min/1.73 m2). 4. Administer 25 mg once daily to patients with severe renal impairment (estimated glomerular filtration rate [eGFR] ≥ 15 mL/min/1.73 m2 and < 30 mL/min/1.73 m2) or end-stage renal disease (ESRD) requiring hemodialysis or peritoneal dialysis (estimated glomerular filtration rate [eGFR] < 15 mL/min/1.73 m2). Administer this medicine regardless of the timing of dialysis.

Ingredients

Manufacturer
Celltrion Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in type 2 diabetes mellitus

  • Difficulty in blood sugar control for patients with type 2 diabetes
View approved original text

This medication is used to help control blood sugar levels in patients with type 2 diabetes. It can be administered alone or in combination with dietary and exercise therapy, and can also be used alongside metformin for those starting diabetes medication for the first time. If blood sugar control is difficult due to monotherapy with sulfonylureas, metformin, thiazolidinediones, or insulin, this medication can be added to enhance effectiveness. Additionally, it can be added to treatment regimens that are insufficient for blood sugar control. Therefore, this medication aids in improving blood sugar control in patients with type 2 diabetes.

How to take

Adult dose

Administer 100mg once daily as monotherapy or combination therapy; the maximum daily dose is 100mg. This medicine may be taken with or without food. When coadministered with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of sulfonylurea- or insulin-induced hypoglycemia (see Precautions for Use, 5. General Precautions). Patients with renal impairment Because dose adjustment according to renal function is required, assessment of renal function is recommended before starting this medicine and periodically during treatment. 1. No dose adjustment is required in patients with mild renal impairment (estimated glomerular filtration rate [eGFR] ≥ 60 mL/min/1.73 m2 and < 90 mL/min/1.73 m2). 2. No dose adjustment is required in patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 45 mL/min/1.73 m2 and < 60 mL/min/1.73 m2). 3. Administer 50 mg once daily to patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 30 mL/min/1.73 m2 and < 45 mL/min/1.73 m2). 4. Administer 25 mg once daily to patients with severe renal impairment (estimated glomerular filtration rate [eGFR] ≥ 15 mL/min/1.73 m2 and < 30 mL/min/1.73 m2) or end-stage renal disease (ESRD) requiring hemodialysis or peritoneal dialysis (estimated glomerular filtration rate [eGFR] < 15 mL/min/1.73 m2). Administer this medicine regardless of the timing of dialysis.

Precautions

This medication is used for diabetes treatment, and severe allergic reactions may occur during use, requiring caution. If symptoms of hypersensitivity such as skin rash, angioedema, or difficulty breathing occur within 3 months of starting the medication, it should be discontinued immediately and a doctor should be consulted. Additionally, serious side effects including acute pancreatitis have been reported; therefore, if symptoms such as abdominal pain, nausea, or vomiting occur during use, medical personnel should be notified immediately. This medication should not be used in patients with type 1 diabetes or diabetic ketoacidosis, and should not be administered if there is an allergy to the drug or its components. Patients with impaired renal function may have difficulty excreting the medication, requiring dose adjustments, and it is recommended to have regular kidney function tests. Hypoglycemic symptoms may occur during treatment, especially when used in conjunction with insulin or sulfonylureas, increasing the risk, so blood sugar levels should be monitored closely. Furthermore, severe joint pain or skin blistering may occur after medication administration; if such symptoms are present, the physician should be notified immediately. Women who are pregnant or breastfeeding are advised not to use this medication due to uncertain safety. Elderly patients may have reduced kidney function, necessitating dose adjustments and kidney function tests. In case of overdose, general emergency treatment should be administered, and some of the drug may be removed via hemodialysis if necessary. This medication may increase the risk of hypoglycemia when used in combination with other hypoglycemic agents, so dose adjustment may be necessary when combined. Drug interactions are relatively rare; however, it is advisable to consult a doctor when taking certain medications. If there are any unusual symptoms or suspected side effects during use, immediate consultation with medical personnel is required.

Side effects

  • Hypersensitivity
  • anaphylaxis
  • angioedema
  • Stevens-Johnson syndrome
  • exfoliative skin disease
  • acute pancreatitis
  • hypoglycemia
  • upper respiratory tract infection
  • nasopharyngitis
  • headache
Show 29 more
  • diarrhea
  • abdominal pain
  • nausea
  • constipation
  • vomiting
  • severe and disabling arthralgia
  • bullous pemphigoid
  • myalgia
  • limb pain
  • back pain
  • interstitial lung disease
  • pruritus
  • thrombocytopenia
  • rhabdomyolysis
  • elevated liver enzymes
  • acute renal failure
  • pneumonia
  • diabetes complications
  • metabolic acidosis
  • falls
  • cardiac arrest
  • indigestion
  • dizziness
  • increased blood triglycerides
  • gastritis
  • weight loss
  • hypertension
  • hypernatremia
  • erectile dysfunction

Not everyone experiences these, and they can vary from person to person.

Storage

Store this medication in a tightly closed container to prevent air or moisture ingress, and keep it at room temperature between 1 and 30 degrees Celsius. Proper storage will help maintain the effectiveness and safety of the drug.

Appearance and packaging

Appearance

Light orange, round, biconvex film-coated tablet

Package unit

28 tablets (14 tablets/PTP x 2) - 14 tablets/PTP [28 tablets (14 tablets/PTP x 2)], 30 tablets (10 tablets/PTP x 3) - 10 tablets/PTP [30 tablets (10 tablets/PTP x 3)]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.